Highlights

Overview

Despite a steady deterioration of trading conditions throughout the year, a marked improvement in second half performance and the acquisition of Pharmed, Imres and S&B Commercials, resulted in the Imperial Group achieving record revenue and operating profit in the 2015 financial year.